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1. Introduction
  Leptospirosis is a zoonotic infection with higher incidence 
in tropics, caused by the pathogenic spirochete belonging 
to the genus Leptospira, family Leptospiraceae, and order 
Spirochaetales[1]. The epidemiology of leptospirosis has 
modified and is increasingly identified as one of the 
emerging infectious disease worldwide. This may be due to 
changes in animal husbandry, climate, sanitation, changes 
in environment and human behaviour[2]. The commonest 
form of the disease, leptospirosis is the self-limiting and 
nonfatal, but its severe form Weil’s disease results in 
multi-organ failure and has high mortality[1, 3]. We present 
an uncommon presentation of leptospirosis, acalculous 
cholecystitis, in this report.
2. Case report
  A 30 year old man, a manual labourer, presented with 
complaints of fever of 3 days and right upper abdominal 
pain with associated vomiting of 1 day duration. He also 
gave history of malaise, body aches and myalgia of 3 days. 
On clinical examination he was febrile, had muscular 
tenderness, mild dehydration. He was hemodynamically 
stable and examination of abdomen showed mild tenderness 
in the right hypochondria. Other systemic examinations 
were within normal limits. Investigations done showed total 
leukocyte count was 11 300/dL with 72% neutrophilia and 
platelet count was 150 000/dL. His serum bilirubin was
2.8 mg/dL(direct being 1.8 mg/dL), SGOT/SGPT were 48 IU/64 
IU, alkaline phosphate and GGTP were 2 014 IU and 400 
IU respectively. Routine examination of urine was normal. 
Sonogram of the abdomen showed distended gall bladder 
with sludge. With the clinical features and investigations, 
provisional diagnosis of acalculous cholecystitis was made. 
He was started on intravenous crystalloids and supportive 
care; had no improvement of symptoms. 
  On day 3 he developed sub conjunctival haemorrhages, 
purpura, severe myalgia and slipped into hypotension, 
followed by anuria and respiratory distress.  On 
reassessment, diagnosis of leptospirosis - Weil’s disease 
was established; as he fulfilled the modified Faine’s 
criteria[4]. 
  The repeat blood counts were 12 800/dL and platelets were 
20 000/dL. Urine analysis showed albumin +++, with RBC 
and WBC casts. Urine dark ground microscopy showed no 
Leptospira, but Ig M and PCR for Leptospira were positive [5].
The serum bilirubin was 7.8 mg; alkaline phosphate - 880 IU;
urea - 68 mg; creatinine - 2.4 mg; CPK - 3 300 IU; and 
serum potassium - 6.2 mEq /dL. He was started on assisted 
ventilation, hemodialysis, intravenous crystalline penicillin, 
hydrocortisone, platelet transfusions and other supportive 
measures.
 There was a gradual improvement and was weaned of 
assisted ventilation on day 7. He was discharged from 
hospital on day 9 with mild jaundice, near normal renal 
functions and good urine output.   
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3. Discussion
  Leptospirosis has emerged as a leading infectious disease 
worldwide. It is increasingly recognised as a recreational 
disease in the western world. It still remains as an 
occupational disease in the tropical countries affecting the 
lower socioeconomic strata[1-3]. The spirochete enters the 
humans through the mucous membranes or abraded skin 
on contact with contaminated water from environmental 
sources. The leptospira rapidly multiplies in the blood and 
spreads rapidly to other tissues.
  Leptospirosis is known to be a great masquerade, for 
its variability in its clinical features. Katz AR et al[6] 
retrospectively assessed the clinical presentation and 
treatment of 353 cases of laboratory-confirmed leptospirosis 
in Hawaii during 1974 to 1998, and found non-specific 
symptoms as the commonest presentation. Most of the 
atypical presentations go undetected in early stages of 
the disease. We have reported a rare case of leptospirosis 
presenting with Sweet’s syndrome and central nervous 
vasculitis[7]. 
  Acalculous cholecystitis is an uncommon presentation of 
leptospirosis, and the pathogenesis could be immunogenic 
reaction against the infiltrating Leptospira in the gall 
bladder. Gross examination of the gall bladders removed at 
surgery in cases of leptospirosis presenting as cholecystitis, 
had no calculi but revealed bile stained thickened 
walls with smooth serosal surface[8]. Guarner J[8] by 
histopathological study of gall bladder showed sub-mucosal 
mononuclear infiltration with oedema and positive immune-
histochemistry for Leptospira; and even found spirochete 
in one specimen. They  suggest pathologic studies for 
leptospirosis on formalin-fixed, paraffin-embedded tissues, 
if cholecystectomy is done in febrile patients with suspicious 
environmental or animal exposure.
  Leptospira have a rich content of adhesins endowed with 
multifunctional biological activities. These include the 
pathogens adhesion to host tissue components, plasminogen 
activation, and its resistance to complement. There are 
more studies to be done to understand the pathogenesis of 
leptospirosis[9].
  The simplest method for diagnosis of leptospirosis is 
identifying motile spirochetes in urine by dark ground 
microscopy. The more definitive tests for leptospirosis 
is by PCR, culture of blood or urine, and or a positive 
microscopic agglutination test or detecting Ig-M against 
leptospira[1,3,7,8,10]. Our patient had positive IgM and PCR for 
leptospira and also fulfilled the modified Faine’s criteria for 
the diagnosis of leptospirosis[5]. 
  A few case reports, of leptospirosis presenting as acalculous 
cholecystitis were found in review of literature[11,12]. 
Vilaichone RK in his report of three cases could not identify 
Leptospira in the surgically removed gall bladder but 
could get rising titres by serology . Three case reports of 
acalculous cholecystitis associated with pancreatitis were 
found in literature, and our patient did not have evidence of 
pancreatitis[13-15].
  The disease can be treated with doxycycline, penicillin, 
ceftrioxone or azithromycin; and prevented by administering 
doxycycline as prophylaxis in individuals at risk[16-18]. 
The controversy remains on the management of Leptospira 
induced acute cholecystitis  by surgical or medical therapy. 
In review of literature we were unable to get enough data 
to support[19]. We believe that appropriate and early 
institution of antibiotics would be sufficient to manage 
acalculous cholecystitis due to leptospirosis rather than 
cholecystectomy.  
  We indent to highlight acalculous cholecystitis as a rare 
but significant clinical presentation of leptospirosis, which 
would result in adverse outcome. At times, clinicians from 
tropics mistake leptospirosis for non-medical conditions and 
surgical treatment is initiated. Early institution of antibiotics 
would be sufficient to treat acalculous cholecystitis due to 
leptospirosis rather than cholecystectomy.  
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